Search Results

There are 7822 results for: content related to: Why do I treat HBeAg-negative chronic hepatitis B patients with pegylated interferon?

  1. You have free access to this content
    Optimal therapy of chronic hepatitis B: how do I treat my HBeAg-negative patients?

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 107–113, Mauro Viganò, Federica Invernizzi and Pietro Lampertico

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12717

  2. Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B

    Liver International

    Volume 35, Issue 2, February 2015, Pages: 473–481, Haiqing Wu, Gangde Zhao, Fangxing Qian, Kehui Liu, Jingdong Xie, Huijuan Zhou, Jie Xu, Yumin Xu, Yan Han, Qing Xie and Hui Wang

    Version of Record online : 13 MAR 2014, DOI: 10.1111/liv.12491

  3. You have free access to this content
    HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 127–132, Jiannis Vlachogiannakos and George V. Papatheodoridis

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12404

  4. Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa-2a in hepatitis C null responders

    Liver International

    Volume 35, Issue 10, October 2015, Pages: 2275–2284, Balazs Fülöp, Michael Biermer, Markus Cornberg, Heiner Wedemeyer, Kerstin Port, Renate Heyne, Stefan Zeuzem, Kai-Henrik Peiffer, Tania Welzel, Adam Herber, Peter Buggisch, Christoph Moser, Sabine Stoll, Ulrich Alshuth and Thomas Berg

    Version of Record online : 20 APR 2015, DOI: 10.1111/liv.12832

  5. Pegylated interferon α-2a plus ribavirin for decompensated hepatitis C virus-related cirrhosis: relationship between efficacy and cumulative dose

    Liver International

    Volume 34, Issue 10, November 2014, Pages: 1522–1531, Yan Xu, Wenqian Qi, Xu Wang, Ping Zhao, Yonggui Zhang, Qian Zhang, Shaoyou Qin and Jiangbin Wang

    Version of Record online : 12 DEC 2013, DOI: 10.1111/liv.12417

  6. You have free access to this content
    A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative

    Hepatology

    Volume 42, Issue 1, July 2005, Pages: 77–85, Vassiliki-Anastasia Sypsa, Konstantinos Mimidis, Nicholas C. Tassopoulos, Dimitrios Chrysagis, Themistoklis Vassiliadis, Antonios Moulakakis, Maria Raptopoulou, Caterina Haida and Angelos Hatzakis

    Version of Record online : 16 JUN 2005, DOI: 10.1002/hep.20738

  7. You have free access to this content
    Optimal therapy in genotype 4 chronic hepatitis C: finally cured?

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 27–34, Wael Abdel-Razek and Imam Waked

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12724

  8. You have free access to this content
    Treatment of HBeAg-negative chronic hepatitis B with pegylated interferon

    Liver International

    Volume 31, Issue s1, January 2011, Pages: 90–94, Pietro Lampertico, Mauro Viganò and Massimo Colombo

    Version of Record online : 4 JAN 2011, DOI: 10.1111/j.1478-3231.2010.02386.x

  9. You have free access to this content
    HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 112–119, Jia-Horng Kao

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12400

  10. You have free access to this content
    Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 54–60, Mitchell L. Shiffman and Rafael Esteban

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02718.x

  11. You have free access to this content
    HBV Trials and Treatments

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 647A–705A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26856

  12. OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 120–129, Raffaele Bruno, Giuseppe Cariti, Paola Nasta, Amedeo Capetti, Veronica Ravasio, Massimo Galli, Enzo Raise, Giulio Palmieri, Claudio Iannacone and Massimo Puoti

    Version of Record online : 11 AUG 2014, DOI: 10.1111/liv.12641

  13. You have free access to this content
    Optimal therapy of chronic hepatitis B: how do I treat HBeAg-positive patients?

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 100–106, Jiannis Vlachogiannakos and George V. Papatheodoridis

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12719

  14. You have free access to this content
    Review article: the potential of interferon and nucleos(t)ide analogue combination therapy in chronic hepatitis B infection

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 7, October 2016, Pages: 653–661, M. Viganò, F. Invernizzi, G. Grossi and P. Lampertico

    Version of Record online : 16 AUG 2016, DOI: 10.1111/apt.13751

  15. You have free access to this content
    Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 88–102, Tarik Asselah and Patrick Marcellin

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02699.x

  16. You have free access to this content
    Response-guided and -unguided treatment of chronic hepatitis C

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 64–73, K. Rajender Reddy, Frederick Lin and Fabien Zoulim

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02713.x

  17. You have free access to this content
    Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 116–124, Fabien Zoulim and Stephen Locarnini

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12069

  18. You have free access to this content
    New therapeutic perspectives in HBV: when to stop NAs

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 146–153, Cristina Pérez-Cameo, Mònica Pons and Rafael Esteban

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12398

  19. You have free access to this content
    2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 2–8, Vincenza Calvaruso and Antonio Craxì

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02703.x

  20. You have free access to this content
    The role of HBsAg quantification for monitoring natural history and treatment outcome

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 125–132, Michelle Martinot-Peignoux, Martine Lapalus, Tarik Asselah and Patrick Marcellin

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12075